Altimmune, Inc. (ALT) Net margin 2016–2025
Altimmune, Inc. (ALT) net profit margin by fiscal year — reported net income divided by reported revenue.
-214861.0%FY2025 · since FY2016: -342.6% → -214861.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -214861.0% | +260434.0 pp |
| FY2024 | -475295.0% | -454532.8 pp |
| FY2023 | -20762.2% | — |
| FY2021 | -2201.4% | -1602.2 pp |
| FY2020 | -599.2% | -245.5 pp |
| FY2019 | -353.7% | +25.4 pp |
| FY2018 | -379.2% | +53.2 pp |
| FY2017 | -432.3% | -89.7 pp |
| FY2016 | -342.6% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice